EGFR Reloaded: Finding New Ways to Shape Pancreatic Cancer Epigenome
Kayla C LaRue1, Martin E Fernandez-Zapico2
1Schulze Center for Novel Therapeutics, Division of Oncology Research; Mayo Clinic Graduate School of Biomedical Sciences, Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.
Cellular and Molecular Gastroenterology and Hepatology
|March 7, 2023
Abstract
No abstract available in PubMed .
Related Concept Videos
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K